There were 3 unmet needs in CIDP including the lack of specific biomarkers for the disease, weighing the relative value of various metrics, and understanding the optimal timing and approach to assess ...
Navenibart is a monoclonal antibody inhibitor of plasma kallikrein that aims to provide rapid, sustained, and convenient HAE attack prevention. Navenibart, an investigational long-acting monoclonal ...
Rising or critical antibody titers occurred at similar rates in fetal antigen-negative and -positive pregnancies, limiting their value for HDFN prediction. Monitoring for hemolytic disease of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback